Drug could be promising new option against eczema
A pill called upadacitinib, already approved for treating rheumatoid arthritis, might also ease another common immunological condition—eczema.
- Next story COVID-19 has slowed medical innovations, study shows
- Previous story In utero exposure to tiny air pollution particles is linked to asthma in preschoolers
Explore more
- Legal adviser to Giuliani hopes Trump will join court fight over materials seized in FBI raid
A legal adviser to Rudy Giuliani said he hopes former President Donald... - ‘Breakthrough’ COVID infections after vaccination very rare: study
(HealthDay)—COVID-19 “breakthrough” infections, where someone who’s been fully vaccinated becomes infected nonetheless,... - CDC advisers suggest resuming use of Johnson & Johnson vaccine
- As Afghan women, we finally have a seat at peace talks. Don’t abandon us
After two decades of war, this can be a historic year of... - MLB Raises ALS Awareness With Lou Gehrig Day
Gwen Peterson, who has Lou Gehrig’s Disease, is one of the many... - Trump Administration Secretly Seized Phone Records of Times Reporters
The admission by the Biden Justice Department followed similar recent disclosures to... - How the Coronavirus Overwhelmed India
Complacency and lack of preparation by the government pushed the country into... - Spaniards hold their breath as sweeping virus measures end
Spain will relax nationwide pandemic measures this weekend, including travel restrictions, but... - With India in crisis, Modi presses ahead with $1.8 billion parliament renovation
- Gene therapy in Alzheimer’s disease mouse model preserves learning and memory
Researchers at University of California San Diego School of Medicine, with colleagues...